Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: at a glance

HIGHLIGHTS

• who: TYPE and colleagues from the Alabama State University, United States have published the research work: Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance, in the Journal: (JOURNAL)

SUMMARY

Typical, cancerous brains tumors are prone to relapse (brain metastases have quite a median survival of 8 months, even aggressive primary brain cancers have median survival of 14.2 months) and remain an unmet clinical challenge (Stupp et_al, 2005; Au et_al, 2017). A number of promising medications for the treatment of neurological diseases have been . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.